This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Ophthalmic Drugs Market 2011-2015

01. Executive Summary

02. Introduction

03. Market Coverage

Market Overview

Key Offerings

04. Market Landscape

04.1 Global Ophthalmic Drugs Market

Market Size and Forecast

04.2 Market Segmentation of Ophthalmic Drugs

04.3 Five Forces Analysis

05. Geographical Segmentation

06. Rate of Incidence and Prevalence

07. Vendor Landscape

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Key Vendor Analysis

14.1 Alcon Inc.

Business Overview

Key Information

SWOT Analysis

14.2 Allergan, Inc.

Business Overview

Key Information

SWOT Analysis

14.3 Merck and Co., Inc.

Business Overview

Key Information

SWOT Analysis

14.4 Pfizer Inc.

Business Overview

Key Information

SWOT Analysis

14.5 Novartis AG

Business Overview

Key Information

SWOT Analysis

15. Other Reports in this Series

List of Exhibits:

Exhibit 1: Global Ophthalmic Drugs Market 2011-2015 (US$ billion)

Exhibit 2: Global Ophthalmic Drugs Market by Drug Class

Exhibit 3: Global Ophthalmic Drugs Market by Geographical Segmentation 2011

Exhibit 4: Global Ophthalmic Drugs Market by Vendor Segmentation 2011

To order this report:

Drug_and_Medication Industry : Global Ophthalmic Drugs Market 2011-2015

Contact Nicolas: nicolasbombourg@reportlinker.comUS: (805)-652-2626Intl: +1 805-652-2626

SOURCE Reportlinker

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,047.58 -22.82 -0.13%
S&P 500 2,106.30 -8.19 -0.39%
NASDAQ 4,969.7320 -47.1970 -0.94%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs